felin
macrophag
studi
use
monoclon
antibodi
mab
fipv
strain
adher
cell
recov
felin
lung
periton
caviti
phagocytos
fix
red
blood
cell
form
fcmediat
rosett
enhanc
viru
infect
mab
investig
inocul
alveolar
macrophag
mixtur
viral
suspens
mab
examin
cell
intracellular
viral
antigen
immunofluoresc
assay
amount
infecti
viru
supernat
fluid
incub
replic
fipv
macrophag
enhanc
nonneutr
mab
recogn
peplom
protein
transmembran
protein
viru
even
among
mab
abil
neutral
fipv
strain
revers
enhanc
viru
infect
dilut
enhanc
suppress
pretreat
mab
protein
enhanc
reduc
use
f
ab
fragment
mab
result
demonstr
antibodydepend
enhanc
ade
fipv
infect
macrophag
replic
fipv
strain
macrophag
fipv
antibodyposit
cat
enhanc
antibodyneg
cat
felin
infecti
periton
viru
fipv
famili
coronavirida
genu
coronaviru
produc
chronic
progress
immunologicallymedi
diseas
domest
exot
cat
present
time
practic
method
immun
report
cat
immun
virulenceattenu
live
inactiv
fipv
protect
virul
fipv
challengeexposur
cat
immun
close
relat
coronavirus
felin
hohdatsu
etal
enter
coronaviru
fecv
canin
coronaviru
ccv
transmiss
gastroenter
viru
tgev
also
sensit
exposur
virul
f
p
v
infect
f
p
v
onset
diseas
acceler
cat
f
p
v
antibodi
comparison
without
f
p
v
antibodi
cat
passiv
immun
f
p
v
antibodi
infect
virul
fipv
sever
symptom
observ
die
soon
infect
p
h
e
n
e
n
consid
caus
mechan
similar
dengu
shock
syndrom
antibodydepend
enhanc
ade
viral
infect
occur
subneutr
antivir
antibodi
result
format
virusantibodi
complex
attach
complex
cell
fc
receptor
intern
mononuclear
phagocyt
demonstr
viral
infect
dengu
viru
infect
felin
macrophag
k
n
w
n
one
target
cell
fipv
vitro
growth
f
p
v
felin
macrophag
report
stoddart
scott
detail
e
f
p
v
infect
unknown
paper
describ
vitro
e
f
p
v
infect
felin
macrophag
strain
fipv
obtain
dr
mc
horzinek
state
univers
utrecht
netherland
strain
fecv
obtain
dr
j
mckeirnan
washington
state
univers
pullman
strain
passag
time
felin
fetal
cell
cultur
store
use
prepar
fusion
spleen
cell
balbc
mice
immun
fipv
strain
mous
myeloma
cell
mab
use
present
studi
recogn
protein
viru
recogn
protein
viru
mab
abil
neutral
fipv
strain
recogn
differ
epitop
protein
viru
mab
neutral
abil
mab
character
author
cultur
fluid
hybridoma
use
experi
macrophag
collect
coronaviru
antibodyneg
adult
cat
alveolar
macrophag
obtain
alveolar
wash
hank
balanc
salt
solut
hbss
recov
cell
spun
wash
time
hbss
x
cellsml
suspens
made
growth
medium
eagl
minimum
essenti
medium
contain
leibovitz
medium
fetal
calf
serum
unit
penicillin
per
ml
txg
streptomycin
per
ml
suspens
transfer
ml
volum
well
multipl
contain
cover
glass
cell
incub
h
supernat
fluid
remov
cell
layer
wash
hbss
remov
nonadher
cell
addit
growth
medium
cell
incub
h
wash
hbss
cell
thu
obtain
use
macrophag
experi
periton
macrophag
recov
cat
lavag
periton
caviti
hbss
day
intraperiton
administr
mlkg
liquid
paraffin
recov
cell
treat
manner
alveolar
macrophag
use
experi
macrophag
identifi
basi
phagocytosi
fix
red
blood
cell
fcmediat
roset
phagocytosi
carri
ad
sheep
red
blood
cell
srbc
fix
glutaraldehyd
solut
cultur
macrophag
incub
h
incub
cell
wash
phosphat
buffer
salin
pb
fix
methanol
stain
giemsa
solut
fcmediat
roset
induc
ad
srbc
coat
rabbit
antisrbc
antibodi
cultur
macrophag
incub
mixtur
h
incub
specimen
gentli
wash
pb
observ
microscop
mixtur
mab
recogn
peplom
protein
transmembran
protein
nucleocapsid
protein
n
fipv
strain
use
primari
antibodi
mab
ad
acetonefix
cell
allow
stand
rain
specimen
wash
pb
three
time
stain
rabbit
antimouseigg
iga
igm
serum
conjug
fluorescein
isothiocyan
mile
laboratori
napervil
usa
left
wash
pb
mount
glycerol
buffer
observ
fluoresc
microscop
confluent
cell
monolay
plastic
petri
dish
inocul
viru
dilut
ml
amount
viru
adsorpt
min
inocul
cultur
cover
ml
agar
overlay
medium
consist
bacto
agar
mem
cultur
incub
incub
day
stain
incub
h
second
overlay
medium
contain
neutral
red
infecti
titer
express
plaqueform
unit
pfu
equal
amount
mab
viral
suspens
allow
react
h
mixtur
inocul
ml
volum
well
multipl
cultur
macrophag
incub
day
adsorpt
h
ml
growth
medium
ad
incub
h
co
z
incub
cultur
supernat
determin
pfu
recov
cover
slip
examin
ifa
percentag
ade
obtain
follow
formula
percent
ade
bb
x
rate
posit
ifa
pfu
presenc
antibodi
b
rate
posit
ifa
pfu
absenc
antibodi
igg
purifi
mous
ascit
fluid
affin
chromatographi
use
protein
sepharos
pharmacia
sweden
purifi
igg
dialyz
sodium
acet
buffer
ph
mg
pepsin
per
igg
ad
specimen
digest
h
subsequ
n
naoh
ad
adjust
ph
reaction
termin
supernat
obtain
centrifug
x
g
min
load
onto
protein
sepharos
column
flowthrough
fraction
use
f
ab
fragment
fraction
retain
ifa
abil
detect
fipv
antigen
two
felin
coronaviru
antibodyneg
cat
oral
inocul
tissu
cultur
infecti
dose
fecv
strain
antibodi
felin
coronaviru
confirm
present
ifa
techniqu
neutral
test
day
inocul
cat
use
recov
macrophag
h
e
r
e
n
cell
recov
alveolu
periton
caviti
cat
demonstr
fcmediat
roset
phagocytosi
fix
red
cell
fig
fig
figur
show
inocul
onto
alveolar
macrophag
ade
suppress
increas
concentr
protein
fig
effect
ade
igg
purifi
mous
ascit
fluid
f
ab
fragment
fc
fragment
remov
igg
digest
pepsin
studi
alveolar
macrophag
percent
enhanc
determin
ifa
regardless
concentr
antibodi
ade
suppress
f
ab
z
fragment
igg
fig
macrophag
recov
alveolu
periton
caviti
cat
experiment
infect
fecv
strain
coronaviru
antibodi
neg
cat
alveolar
periton
macrophag
incub
day
inocul
fipv
strain
thirtysix
hour
later
viru
replic
cell
compar
tabl
show
result
viru
replic
distinctli
better
periton
alveolar
macrophag
recov
antibodyposit
cat
antibodyneg
cat
viru
inocul
onto
macrophag
recov
antibodyposit
cat
cours
viral
antigen
detect
ifa
infecti
viru
found
even
cultur
supernat
periton
alveolar
macrophag
compar
viral
replic
tend
better
vitro
growth
fipv
first
demonstr
cultur
cell
periton
exud
experiment
infect
kitten
macrophag
inflammatori
lesion
infect
cat
shown
contain
viru
electron
microscop
observ
suggest
macrophag
hohdatsu
et
stoddart
scott
recent
report
growth
fipv
macrophag
recov
periton
caviti
present
studi
adher
cell
recov
alveolu
periton
caviti
phagocytos
fix
red
blood
cell
abl
form
fcmediat
rosett
phenomena
indic
adher
cell
properti
macrophag
adher
cell
inocul
fipv
strain
cell
reveal
viru
antigenposit
indirect
fluoresc
assay
supernat
fluid
contain
x
pfuml
viru
howev
cytopath
effect
observ
suggest
infect
persist
lead
viruscarri
state
antibodybound
viru
invad
cell
via
fc
receptor
infect
enhanc
phenomenon
observ
macrophag
macrophagelik
cell
line
variou
virus
present
studi
disclos
viral
infect
alveolar
macrophag
enhanc
intervent
mab
without
viru
neutral
activ
tabl
enhanc
suppress
blockad
fc
region
antibodi
fig
even
mab
abil
neutral
fipv
strain
revers
enhanc
infect
dilut
fig
c
neutral
mab
use
studi
recogn
differ
epitop
protein
viru
mab
show
enhanc
infect
regardless
dilut
fig
inhibit
viru
prolifer
mab
may
exert
adsorpt
virus
cell
detail
mechan
neutral
enhanc
fipv
infect
neutral
mab
studi
differ
viral
type
consid
close
relat
ade
infect
caus
dengu
shock
syndrom
dengu
viru
infect
discov
exist
least
sero
type
fipv
use
mab
abil
neutral
fipv
strain
effect
type
differ
ade
fipv
infect
studi
futur
vennema
et
al
combin
protein
gene
fipv
vaccinia
viru
cat
immun
recombin
viru
demonstr
protect
challeng
virul
fipv
onset
diseas
acceler
immun
observ
support
result
indic
mab
protein
show
ade
furthermor
present
studi
show
mab
protein
also
enhanc
activ
fecv
known
antigen
crossreact
fipv
cat
previous
inocul
fecv
show
acceler
onset
diseas
upon
infect
virul
fipv
replic
fipv
distinctli
better
macrophag
recov
fecv
antibodyposit
cat
antibodyneg
cat
also
remain
unsolv
whether
interest
phenomenon
due
e
cytophil
antibodi
studi
shown
viral
growth
better
activ
macrophag
also
obtain
better
replic
fipv
periton
macrophag
induc
stimul
liquid
paraffin
alveolar
macrophag
tabl
e
fipv
infect
also
studi
take
consider
differ
activ
macrophag
possibl
use
cell
believ
macrophag
properti
determin
e
fipv
infect
investig
take
cell
homogen
consider
